MS
Morgan Stanley
$228.51
▲ +0.37%
+$0.84
NYSE · Financial · Capital Markets
Morgan Stanley
MS · NYSE · Financial · Capital Markets
$228.51
▲ +0.37% · +$0.84 today
fundamentals63.6 /100 vs peers
solid
Revenue growth (TTM)16.3
12% above Sector 5Y avg avg · favorableSector 5Y avg: 14.6
EPS growth (TTM)29.4
58% above Sector 5Y avg avg · favorableSector 5Y avg: 18.6
EPS forecast (5Y)11.3
6% below Sector fwd avg avgSector fwd avg: 11.9
EPS next year7.8
solid pace
EPS growth (Q/Q)32.1
strong pace
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| MSMorgan Stanley | $360.43B | 20.7 | +14.2% | 64 |
| XBISPDR S&P Biotech ETF | $0 | 0.0 | - | 83 |
| SCHWThe Charles Schwab Corporation | $179.34B | 20.4 | +21.2% | 81 |
| NUNu Holdings Ltd. | $67.05B | 21.4 | - | 81 |
| EVREvercore | $12.95B | 18.9 | +47.3% | 79 |
